US: DOJ may not challenge Aetna-CVS deal

Shares of CVS Health Corp and Aetna Inc jumped Thursday, July 12, on reports that the US Department of Justice (DOJ) will not challenge the US$69 billion purchase of the Hartford health insurer.

Bloomberg reported the DOJ’s decision, citing publication Reorg Research.

Shares of Aetna closed at $191.08, up less than 2%, after climbing nearly 2.5% earlier in the day. CVS ended the day at US$67.99, up 1% after jumping more than 4% at one point during the day.

The federal government blocked Aetna last year from buying Humana in Louisville, in a US$37 billion deal. The DOJ said the acquisition was anti-consumer and a federal judge agreed, striking down the deal.

Full Content: Bloomberg

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.

...
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 18.188.39.45

Please verify email or join us
to access premium content!